Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-53,573
Closed -$3.83M 564
2023
Q4
$3.83M Buy
53,573
+37,741
+238% +$2.63M 0.61% 31
2023
Q3
$1.1M Buy
15,832
+4,801
+44% +$363K 0.17% 200
2023
Q2
$893K Buy
+11,031
New +$901K 0.14% 214
2022
Q4
Sell
-22,057
Closed -$1.42M 536
2022
Q3
$1.42M Buy
22,057
+3,753
+21% +$260K 0.26% 115
2022
Q2
$1.27M Buy
+18,304
New +$1.36M 0.3% 105
2021
Q4
Sell
-9,842
Closed -$726K 487
2021
Q3
$726K Buy
+9,842
New +$738K 0.2% 169
2020
Q2
Sell
-1,420
Closed -$50K 423
2020
Q1
$50K Sell
1,420
-9,404
-87% -$448K 0.1% 234
2019
Q4
$565K Buy
10,824
+6,924
+178% +$345K 0.21% 149
2019
Q3
$197K Buy
3,900
+1,273
+48% +$62.6K 0.56% 81
2019
Q2
$126K Buy
+2,627
New +$121K 0.8% 23
2019
Q1
Sell
-400
Closed -$16K 529
2018
Q4
$16K Buy
+400
New +$16.4K 0.07% 376

Other funds holding HOLX

Pearl River Capital's HOLX Position: Q1 2024 in Review

Pearl River Capital sold out of Hologic (HOLX) in Q1 2024, closing a stake of 53,573 shares — an estimated $3.83M sold.

Pearl River Capital first reported a position in HOLX in Q4 2018 and held it in 11 quarters. The position peaked at $3.83M in Q4 2023. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Pearl River Capital reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Pearl River Capital sold 53,573 Hologic shares in Q1 2024, an estimated $3.83M.
  • Pearl River Capital first reported a position in Hologic in Q4 2018 and held it in 11 quarters.
  • Pearl River Capital's Hologic position peaked at $3.83M in Q4 2023.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Pearl River Capital's 13F filing for Q1 2024, filed 14 May 2024.